Inovio Pharmaceuticals

INO74

Penny Stock

$4.06arrow_drop_up2.26%$0.08

Penny Stock

INO74

$4.06

arrow_drop_up2.26%$0.08

Penny Stock

Performance History

Key Stats
Open	$3.96
Prev. Close	$4.03
EPS	-4.43
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$103.61M
PE Ratio	-

	LOW	HIGH
Day Range	3.78	4.25
52 Week Range	3.78	14.75

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-4.43

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Inovio Pharmaceuticals (INO)

Inovio Pharmaceuticals Inc (INO) is a biotechnology company that specializes in the development of DNA-based immunotherapies and vaccines. The company has a strong focus on utilizing its proprietary technology platform to create novel treatments for a variety of diseases, including cancer and infectious diseases. With a market cap of $XXX billion, Inovio Pharmaceuticals is considered to be a mid-cap stock and is part of the healthcare sector.

The stock price history of Inovio Pharmaceuticals Inc (INO) has been quite volatile in recent years. It has experienced both significant ups and downs, reflecting the speculative nature of the biotech industry. However, in the past year, the stock has shown considerable growth, with a 52-week range of $X to $X. This indicates that the stock has performed well and has the potential for further growth.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Jacqueline E. Shea Ph.D.
Headquarters: Plymouth Meeting
Employees: 184
Exchange: NASDAQ

Keep an eye on Inovio Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Inovio Pharmaceuticals (INO) stock price performance year to date (YTD)?

As of the latest data, Inovio Pharmaceuticals (INO) has a year-to-date price change of -40.01%. Over the past month, the stock has experienced a price change of -29.27%. Over the last three months, the change has been -44.91%. Over the past six months, the figure is -63.46%. Looking at a longer horizon, the five-year price change stands at -86.19%.

help

What is Inovio Pharmaceuticals 's (INO) price per share?

The current price per share for Inovio Pharmaceuticals (INO) is $4.06. The stock has seen a price change of $0.09 recently, indicating a 2.27% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Inovio Pharmaceuticals (INO)?

For Inovio Pharmaceuticals (INO), the 52-week high is $14.75, which is 263.3% from the current price. The 52-week low is $3.79, the current price is 7.27% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Inovio Pharmaceuticals (INO) a growth stock?

Inovio Pharmaceuticals (INO) has shown an average price growth of -7.23% over the past three years. It has received a score of 96 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Inovio Pharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

Is Inovio Pharmaceuticals (INO) a profitable company?

Inovio Pharmaceuticals (INO) has a net income of -$135.12M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -32.95K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$135.23M. Furthermore, the EBITDA is -$114.99M.

help

What is the market capitalization of Inovio Pharmaceuticals (INO)?

Inovio Pharmaceuticals (INO) has a market capitalization of $105.97M. The average daily trading volume is 4.1, indicating the stock's liquidity and investor engagement.